Table 1.
Comparison of different strategies for ubiquitination characterization: from ubiquitinated protein to ubiquitin chain architecture
Levels | Approaches | Advantages | Disadvantages | Application | Refs |
---|---|---|---|---|---|
At the protein level | Ub tagging-based approaches |
• Can remove the majority of non-ubiquitinated proteins • Can identify ubiquitination sites and localize them to proteins |
• Require expressing ubiquitin tag which may behave differently from endogenous ubiquitin and impair the identification accuracy of ubiquitylation • Low efficiency for ubiquitylation identification • Limit its application in tissues |
Screen and validation of ubiquitinated substrates in cells | [34–36] |
Ub antibody-based approaches |
• Can purify endogenous ubiquitinated proteins • Enrich the linkage specific ubiquitylated proteins by linkage-specific antibodies • Application in all samples |
• High cost of antibodies • High background derived from binding proteins • Low efficiency for ubiquitylation identification |
Validation of ubiquitinated substrates and their linkage types in all samples | [37–40] | |
UBD-based approaches |
• Do not require expressing ubiquitin tag and antibodies • Can purify endogenous ubiquitinated proteins • Enrich the linkage specific ubiquitylated proteins by linkage-specific UBDs |
• lower affinity of monoubiquitylated proteins • Low efficiency for ubiquitylation identification • High background derived from UBAs and UBDs |
Screen of ubiquitinated proteins and their linkage types in all samples | [47–55] | |
At the peptide level | Anti-diGly antibody-based approach |
• Can identify large number of ubiquitination sites • High efficiency for ubiquitination identification |
• High cost of antibody • False positive identification generated from ISG15 and NEDD8 modification • Cannot identify N-terminal ubiquitylation sites • Cannot reveal any information on ubiquitin chain topology |
Profiling of ubiquitination sites in all samples | [57–65] |
UbiSite antibody-based approach |
• Can identify large number of ubiquitination sites with high efficiency • Can identify N-terminal ubiquitination sites • Can avoid the interference of ISG15 and NEDD8 modification |
• High cost of antibody • The longer ubiquitin remnants on the ubiquitination sites hamper the identification of the ubiquitinated peptides • Cannot reveal the information on ubiquitin chain topology |
Profiling of ubiquitination sites in all samples | [70] | |
Antibody-free approaches |
• Do not require antibody • Low cost • Can identify large number of ubiquitination sites |
• Low through-put compared with antibody-based approaches • Artifacts derived from ubiquitin mutation and chemical derivatization |
Screen of ubiquitination sites in cells | [75–77] | |
At the topology level | Bottom-up proteomics, e.g. Ub-AQUA and UbiCRest | • Can dissect the ubiquitin chain architecture |
• Cannot well distinguish branched from mixed ubiquitin chains • Low specificity in identifying linkage types • Cannot effectively analyze the heterotypic chains |
Validation of the ubiquitin chain linkage in all samples | [79–86] |
Middle-down proteomics, e.g. Ub-clipping |
• Can dissect the branched ubiquitin chains • Can reveal the ratio of branched to unbranched linkages |
• Cannot dissect the chain linkage types at the branched point | Screen and validation of ubiquitination sites and its topologies in all samples | [91–96] | |
Top-down proteomics |
• Can dissect the branched ubiquitin chains • Can reveal the ratio of branched to unbranched linkages • Can dissect the chain linkage types at the branched point |
• Low signal-to-noise (S/N) fragments with increasing molecular weight • Lack in in sample preparation and analytical approaches |
Application in identifying ubiquitination sites and its topologies in all samples | [28, 97–99] |